International Journal of Molecular Sciences · 2015 · 19 citations · 45 references
MedicineMolecular BiologyOncologyMolecular OncologyNeoplasiaTumor ProgressionCancer Cell SignalingCancer Molecular PathologyCancer ProgressionEsophageal CancerMalignant NeoplasmsOncogenic Signaling PathwaysDna Damage BiomarkersDna Damage InductionDna Damage ResponsesDna Damage SensorsEsophageal PathologyLymph Node Metastasis PrognosisTargeted Molecular TherapyTumor Location Assessment
Primary esophageal small cell carcinoma (PESCC) is a rare, but fatal subtype of esophageal carcinoma. No effective therapeutic regimen for it. P21-activated kinase 1 (PAK1) is known to function as an integrator and an indispensable node of major growth factor signaling and the molecular therapy targeting PAK1 has been clinical in pipeline. We thus set to examine the expression and clinical impact of PAK1 in PESCC. The expression of PAK1 was detected in a semi-quantitative manner by performing immunohistochemistry. PAK1 was overexpressed in 22 of 34 PESCC tumors, but in only 2 of 18 adjacent non-cancerous tissues. Overexpression of PAK1 was significantly associated with tumor location (p = 0.011), lymph node metastasis (p = 0.026) and patient survival (p = 0.032). We also investigated the association of PAK1 with DNA damage, a driven cause for malignancy progression. γH2AX, a DNA damage marker, was detectable in 18 of 24 (75.0%) cases, and PAK1 expression was associated with γH2AX (p = 0.027). Together, PAK1 is important in metastasis and progression of PESCC. The contribution of PAK1 to clinical outcomes may be involved in its regulating DNA damage pathway. Further studies are worth determining the potentials of PAK1 as prognostic indicator and therapeutic target for PESCC.
45
Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text
Gary M. Strauss, James E. Herndon, Michael A. Maddaus et al. · Journal of Clinical Oncology · 2008 · 990 citations · Full text
Medicine, Oncology, Pharmacotherapy +12
Pirta Hotulainen, Eija Paunola, Maria K. Vartiainen et al. · Molecular Biology of the Cell · 2004 · 381 citations · Full text
ERCC1 Isoform Expression and DNA Repair in Non–Small-Cell Lung Cancer
Luc Friboulet, Ken A. Olaussen, Jean‐Pierre Pignon et al. · New England Journal of Medicine · 2013 · 363 citations · Full text